| | |

Altered Herpes Virus Halts Mesothelioma Growth in New Study

altered herpes virus

An altered herpes virus has been shown to stabilize the growth of mesothelioma tumors in half of patients who participated in a new UK study. 

Researchers at the University of Sheffield injected thirteen mesothelioma patients with a cancer cell-seeking version of HSV, the virus that causes herpes. 

The altered herpes virus is not able to replicate in non-dividing cells. This also makes it most destructive inside cancer cells. It is also attenuated or weakened so it does not cause herpes.

Other studies show the virus (HSV1716) can stimulate the immune system against cancer. The new report suggests that it may be a safe new way to fight mesothelioma, too.

The Need for a New Mesothelioma Drug

The FDA has only approved two drug therapies for mesothelioma since the disease was first identified around the 1930s. The first is the chemotherapy drug Alimta approved in 2004. The second is a combination of Opdivo and Yervoy approved earlier this year. 

If the altered herpes virus proves to be safe and effective, it could form the basis of a new mesothelioma drug treatment. It might even make existing treatments more effective. 

At best, current treatments may shrink pleural mesothelioma tumors by a little bit. At worst they can cause serious side effects and may not work at all. Alternative treatments for mesothelioma are urgently needed. 

Testing the Altered Herpes Virus for Mesothelioma

The UK study enrolled 13 patients with malignant pleural mesothelioma to test the altered herpes virus. Five patients already had chemotherapy with Alimta. Eight had not had any chemotherapy yet. Mesothelioma surgery was not an option for any of these patients.

Patients received the treatment through a pleural catheter. This allowed doctors to inject the altered herpes virus directly into the space where mesothelioma tumors grow. Three of the study subjects got one dose, three patients got two doses, and seven patients received four doses. 

“The treatment was well-tolerated with few virus-related adverse events and no dose limiting toxicities,” reports study author Sarah Danson. Tests showed that the treatment also stimulated the patients’ immune systems to help fight their mesothelioma.

Unfortunately, HSV1716 did not shrink any of the mesothelioma tumors. But it did stop tumors from growing in half of the patients for two full months. 

The researchers conclude that this altered herpes virus “demonstrated an anti-tumor immune response” in pleural mesothelioma patients. 

“These results provide a rationale for further studies with this agent in MPM and in combination with other therapies,” writes Dr. Danson.

Sources:

Canson, S, et al, “Oncolytic herpesvirus therapy for mesothelioma – A phase I/IIa trial of intrapleural administration of HSV1716”, October 20, 2020, Lung Cancer, Epub ahead of print, https://linkinghub.elsevier.com/retrieve/pii/S0169500220306590

Similar Posts

  • | |

    Doctors Describe "Concrete Therapeutic Approach" for Mesothelioma

    A team of medical researchers in Italy have achieved what they are calling “excellent” tumor control and survival results in malignant pleural mesothelioma patients using a combination of surgery, chemotherapy, and radiotherapy. Caused by exposure to asbestos, mesothelioma typically spreads quickly across the lung-encasing membrane called the pleura. There is no known cure but treatments are improving. In the current prospective study, 20 malignant pleural mesothelioma patients underwent radical pleurectomy/decortication followed by high doses of radiation. After surgeons removed as much of the visible mesothelioma tumor and surrounding tissue as possible, patients received 50Gy of radiation to the effected side of their chest, delivered in 25 fractions. Regions of particular concern for mesothelioma regrowth got an extra radiation “boost” to…

  • |

    Mesothelioma Still Rising Despite Ban in Ireland

    A study in Ireland confirms that it can take many years for a ban on asbestos to have a measurable impact on a country’s rates of malignant mesothelioma. Mesothelioma is the most serious of a list of diseases – including lung cancer, pleural plaques, asbestosis, and others – linked with exposure to asbestos dust. Affecting the linings around the lungs and other organs, mesothelioma is often resistant to most cancer treatments and may be fatal within a year of diagnosis. According to the International Ban Asbestos Secretariat, Ireland is one of 55 countries that have enacted some type of asbestos ban. However, although Ireland banned asbestos in 2000, a new study published in Cancer Epidemiology shows that incidence of the…

  • | |

    Does Radiotherapy Reduce Mesothelioma Pain?

    A new study says there is not enough evidence to support the use of radiotherapy for the treatment of pain associated with malignant pleural mesothelioma. Researchers at the University of Edinburgh in Scotland reviewed a range of past studies on mesothelioma pain and radiotherapy by searching databases that date back as far as 1974. To be eligible to be included in their review, the study had to focus on malignant pleural mesothelioma and radiotherapy given “with the intent of improving pain”. The study also had to report doses and fractionation of the radiotherapy and how the pain responded. In all, the researchers found eight studies on mesothelioma pain and radiotherapy that met the criteria. Two of the studies were prospective…

  • |

    Website Aims to Protect Homeowners from Mesothelioma

    Australia’s Cancer Council is trying to educate home renovators about their risk for mesothelioma with a new e-learning course. Australia has one of the highest per capita rates of mesothelioma in the world, largely because of several asbestos mining operations that were once located there. Although asbestos has been banned from building products in Australia since 1989, asbestos-linked diseases like mesothelioma, lung cancer, and asbestosis continue to pose a serious health concern. While mesothelioma has traditionally occurred among people exposed to asbestos on the job, Australia is now bracing for another “wave” of mesothelioma victims among homeowners who encounter asbestos while doing their own renovation projects. Cancer Council Australia has launched “kNOw asbestos in your home” in an effort to…

  • | |

    Radiotherapy for Mesothelioma: Better But Still Limited

    A form of highly-targeted radiation therapy for mesothelioma is better than it used to be, but is still risky. That is the message of a recent article on intensity-modulated radiation therapy (IMRT) in Seminars in Thoracic and Cardiovascular Surgery. Author Kenneth E. Rosenzweig, MD, a Radiation Oncologist with Mount Sinai Hospital in New York, reviewed recent studies on IMRT and mesothelioma. He concludes that, while the “troubling toxicity” associated with IMRT when it was first introduced has not been entirely eliminated, the fact that clinicians now have more experience with it is making a positive difference for mesothelioma patients. Before targeted therapies like IMRT were available, high-dose radiation was not usually a feasible option for mesothelioma since the irregular shape…

  • | | |

    Mesothelioma Nurses Ready for New Cases in Australia

    Australia is bracing for an expected new wave of mesothelioma cases in the next decade and the Lung Foundation of Australia is taking action now to get ready. The Foundation has paid for ten nurses from around the country to receive specialized training in helping patients and families cope with mesothelioma. The nurses, who have recently completed the training, are now equipped to lead treatment planning for these complex cancer patients and to help other nurses do the same. Pleural mesothelioma is an aggressive cancer that occurs in the lining around the lungs. It is caused by exposure to asbestos dust, a toxin that was once alarmingly prevalent in Australia where it was mined and heavily used in construction. Because…